ANDI
Overview
ANDI (Advanced Neuro Diagnostic Imaging) is an advanced quantitative imaging software developed by Imeka Solutions, Inc.. It is designed for medical professionals, particularly neurologists and radiologists, to enhance the evaluation of medical images, especially in neuroimaging. Its core function involves processing diffusion-weighted images to map the microstructural properties of white matter in the brain. ANDI provides adjunctive information for use with the complete standard of care evaluation of a patient’s brain health.
The software supports functions such as image review, basic measurements, planning, and visualization, including 3D mapping of white matter tracts from diffusion-weighted MRI sequences. It combines diffusion MRI with artificial intelligence to analyze brain damage, and includes updates like brain volumetry. ANDI generates a DICOM-encapsulated PDF report highlighting bundles with the greatest deviation from a normative range and provides a detailed analysis of all bundles’ microstructural and macrostructural values.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated radiological image processing
- Processing of diffusion-weighted MRI sequences
- 3D mapping of white matter tracts
- Microstructural analysis of white matter
- Volumetric analysis of gray matter brain structure
- Automated segmentation of 33 fiber tracts
- Age- and sex-matched comparison to a normative reference (1,200+ control subjects)
- Longitudinal time points if prior studies are available
- DICOM-encapsulated PDF report generation
- Image review, basic measurements, planning, and visualization (MPR reconstructions)
Use Cases
- Assessing brain damage in patients
- Evaluating neurodegenerative diseases (e.g., Alzheimer's, Multiple Sclerosis, Parkinson's)
- Assisting neurologists and radiologists in providing high-quality patient care
- Quantifying neuroinflammation, demyelination, and axonal loss
- Supporting clinical trial recruitment and tracking therapeutic effects
- Providing adjunctive information for standard of care evaluation of brain health
What Physicians Need to Know
Leverage ANDI's detailed white matter analysis for early and precise assessment of neurodegenerative conditions and brain damage. Utilize the quantitative reports to track disease progression and evaluate therapeutic responses, especially concerning neuroinflammation, axonal degeneration, and demyelination. Integrate ANDI's insights with other clinical data for a comprehensive understanding of a patient's brain health, particularly when subtle white matter changes are suspected. The automated comparison to normative data can assist in identifying significant deviations that might be challenging to detect visually.
ANDI generates DICOM-encapsulated PDF reports, suggesting compatibility with PACS (Picture Archiving and Communication Systems) for seamless integration into existing radiology workflows. The software processes diffusion-weighted MRI images, implying direct integration with MRI scanners or image archives. The mention of CPT 3 codes for quantitative brain MRI assessment suggests potential for streamlined billing and integration with hospital financial systems.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | N/a |
| Deployment | Cloud-based (secure cloud environment) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Neurosurgery, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2025-10-22 | K252298 510(k) | ANDI |
Ratings & Reviews
No reviews yet. Be the first to review this tool!





